Abstract
Increasing emergence of infectious diseases is driving demand for new vaccine technologies capable of improving antigen delivery and protective efficacy. Nanoparticle technology is a modern approach to antigen delivery, capable of stabilizing and increasing the amount of antigen delivered to immune cells. Protein-based nanoparticles are a biodegradable alternative to existing nanomaterials, offering a versatile and biocompatible approach to nanoparticle vaccine delivery. In this chapter, the methods for the synthesis and characterization of protein-based nanocapsule vaccines are discussed. Initially, the requirements for a suitable nanoparticle vaccine are outlined, and finally, methods for the design and synthesis of protein-based nanocapsule vaccines are explained.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Bloom DE, Cadarette D (2019) Infectious disease threats in the twenty-first century: strengthening the global response. Front Immunol 10:549. https://doi.org/10.3389/fimmu.2019.00549
Rappuoli R, De Gregorio E, Del Giudice G et al (2021) Vaccinology in the post−COVID-19 era. Proc Natl Acad Sci U S A 118(3):e2020368118. https://doi.org/10.1073/pnas.2020368118
Sahdev P, Ochyl LJ, Moon JJ (2014) Biomaterials for nanoparticle vaccine delivery systems. Pharm Res 31(10):2563–2582. https://doi.org/10.1007/s11095-014-1419-y
Xiao Y, Shi K, Qu Y et al (2019) Engineering nanoparticles for targeted delivery of nucleic acid therapeutics in tumor. Mol Ther Methods Clin Dev 12:1–18. https://doi.org/10.1016/j.omtm.2018.09.002
Danaei M, Dehghankhold M, Ataei S et al (2018) Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics 10(2):57
Penumarthi A, Basak P, Smooker P et al (2020) Hitching a ride: enhancing nucleic acid delivery into target cells through nanoparticles. In: Daima HK, Pn N, Ranjan S, Dasgupta N, Lichtfouse E (eds) Nanoscience in medicine, vol 1. Springer, Cham, pp 373–457. https://doi.org/10.1007/978-3-030-29207-2_11
Büchel G, Unger KK, Matsumoto A et al (1998) A novel pathway for synthesis of submicrometer-size solid core/mesoporous shell silica spheres. Adv Mater 10(13):1036–1038. https://doi.org/10.1002/(sici)1521-4095(199809)10:13<1036::aid-adma1036>3.0.co;2-z
Möller K, Kobler J, Bein T (2007) Colloidal suspensions of nanometer-sized mesoporous silica. Adv Funct Mater 17(4):605–612. https://doi.org/10.1002/adfm.200600578
Taki A (2014) A new approach to antigen delivery using the nanoparticle templating system. RMIT University, Melbourne
Taki AC, Francis JE, Skakic I et al (2020) Protein-only nanocapsules induce cross-presentation in dendritic cells, demonstrating potential as an antigen delivery system. Nanomed Nanotechnol Biol Med 28:102234. https://doi.org/10.1016/j.nano.2020.102234
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Skakic, I., Francis, J.E., Smooker, P.M. (2022). Design and Synthesis of Protein-Based Nanocapsule Vaccines. In: Thomas, S. (eds) Vaccine Design. Methods in Molecular Biology, vol 2412. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1892-9_17
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1892-9_17
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1891-2
Online ISBN: 978-1-0716-1892-9
eBook Packages: Springer Protocols